U.S. markets closed

IGM Biosciences, Inc. (IGMS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
6.65-0.35 (-5.00%)
At close: 04:00PM EST
6.98 +0.33 (+4.96%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close7.00
Bid4.00 x 900
Ask6.65 x 1100
Day's Range6.43 - 7.10
52 Week Range3.81 - 27.92
Avg. Volume328,265
Market Cap388.321M
Beta (5Y Monthly)0.19
PE Ratio (TTM)N/A
EPS (TTM)-4.90
Earnings DateNov 13, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.90
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for IGMS

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • IGM Biosciences, Inc.
    Daily – Vickers Top Buyers & Sellers for 07/05/2023The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
    Fair Value
    Economic Moat
    5 months agoArgus Research
View more
  • Insider Monkey

    15 Best Falling Stocks To Buy Now

    In this piece, we will take a look at the 15 best falling stocks to buy now. If you want to skip our overview of the current stock market environment and our coverage of the latest stock market news, then you can skip ahead to 5 Best Falling Stocks To Buy Now. With 2023 coming […]

  • GlobeNewswire

    IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension

    – Priorities: clinical development of DR5 agonist in colorectal cancer and T cell engagers in autoimmune disease – – Plans to file IND for IGM-2644 (CD38 x CD3) to treat autoimmune disease – – All clinical development in hematologic oncology indications halted – – Cash runway expected to extend into second quarter 2026 – – Reduction in workforce of approximately 22 percent – MOUNTAIN VIEW, Calif., Dec. 05, 2023 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnol

  • PR Newswire

    Bulletin from Extraordinary General Meeting in Medivir AB (publ)

    Today on 1 December 2023, Medivir AB (publ) (the "Company") held an extraordinary general meeting in Stockholm, whereby the resolution below was adopted. The general meeting was held at Helio GT30 on Grev Turegatan 30 in Stockholm. For more detailed information on the content of the resolution, please see the complete notice of the extraordinary general meeting that is available on the Company's website, Minutes from the extraordinary general meeting will be provided on the said